Site Reference ID/Investigator# 22812 — Dallas, Texas

Site Reference ID/Investigator# 22812 is a clinical research site located in Dallas, Texas, United States 75251.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator# 22812 has participated in 1 clinical trials.

Therapeutic areas: Dyslipidemia, Kidney Disease.

Sponsors: AstraZeneca.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator# 22812?

Site Reference ID/Investigator# 22812 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator# 22812 conducted?

Site Reference ID/Investigator# 22812 has 1 clinical trials on record. Their work covers Dyslipidemia, Kidney Disease.

Is Site Reference ID/Investigator# 22812 accredited by Crixeo Health?

Site Reference ID/Investigator# 22812 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator# 22812?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.